Loading...
P09.32 High therapy compliance in patients treated with Optune® therapy does not depend on demographic data, stage of disease or treatment duration
Introduction: Optune is a novel treatment that is approved for the treatment of patients with newly diagnosed glioblastoma (GBM) and also for patients with recurrent high grade glioma (HGG). Alternating electric fields of low intensity (1-3 V / cm) and intermediate frequency (200 kHz) are delivered...
Na minha lista:
| Udgivet i: | Neuro Oncol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5464128/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox036.288 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|